Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Carcinoma Recurrent”

183 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 183 results

Early research (Phase 1)Study completedNCT00016237
What this trial is testing

Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment

Who this might be right for
Bladder CancerKidney CancerLung Cancer
EMD Serono
Early research (Phase 1)Study completedNCT02437370
What this trial is testing

Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer

Who this might be right for
Metastatic Urothelial Carcinoma of the Renal Pelvis and UreterRecurrent Bladder CarcinomaRecurrent Urothelial Carcinoma of the Renal Pelvis and Ureter+6 more
University of California, Davis 32
Testing effectiveness (Phase 2)Looking for participantsNCT07322263
What this trial is testing

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

Who this might be right for
Bladder CancerNon-Muscle Invasive Bladder Cancer (NMIBC)Urothelial Carcinoma+8 more
Michael A. O'Donnell 174
Not applicableUnknownNCT05027412
What this trial is testing

En Bloc TURBT With Collins Loop vs Conventional TURBT

Who this might be right for
Bladder CancerBladder NeoplasmBladder Urothelial Carcinoma+2 more
Hospital Universitario de Fuenlabrada 80
Not applicableUnknownNCT03230201
What this trial is testing

Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)

Who this might be right for
RecurrenceMetastasisUpper Tract Urothelial Carcinoma+1 more
Peking University First Hospital 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT04739800
What this trial is testing

Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents

Who this might be right for
Fallopian Tube Mucinous AdenocarcinomaOvarian Seromucinous CarcinomaPlatinum-Refractory Fallopian Tube Carcinoma+47 more
National Cancer Institute (NCI) 120
Not applicableLooking for participantsNCT06167057
What this trial is testing

POST URS Chemotherapy Instillation

Who this might be right for
UTUC
Carmel Medical Center 264
Very early researchStudy completedNCT02111941
What this trial is testing

Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid TumorFallopian Tube Mucinous Neoplasm+20 more
Mayo Clinic 19
Testing effectiveness (Phase 2)UnknownNCT03030157
What this trial is testing

Single Versus Long-term Intravesical Instillation Chemotherapy for Recurrence After Nephroureterectomy for Upper Tract Urothelial Carcinoma

Who this might be right for
Intravesical Instillation
RenJi Hospital 220
Large-scale testing (Phase 3)Ended earlyNCT00352079
What this trial is testing

BCG With or Without Gefitinib in Treating Patients With High-Risk Bladder Cancer

Who this might be right for
Bladder Cancer
NCIC Clinical Trials Group 41
Testing effectiveness (Phase 2)Ended earlyNCT04398368
What this trial is testing

Gemcitabine for the Prevention of Intravesical Recurrence of Urothelial Cancer in Patients With Upper Urinary Tract Urothelial Cancer Undergoing Radical Nephroureterectomy, GEMINI Study

Who this might be right for
Stage 0a Renal Pelvis and Ureter Cancer AJCC v8Stage 0a Renal Pelvis Cancer AJCC v8Stage 0a Ureter Cancer AJCC v8+15 more
Mayo Clinic 25
Early research (Phase 1)Not Yet RecruitingNCT07725796
What this trial is testing

Dose-escalation Study of UGN-501 Administered Intravesically in Adult Participants With Recurrent NMIBC

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNMIBCUrothelial Carcinoma Bladder+5 more
UroGen Pharma, Inc., a subsidiary of UroGen Pharma Ltd. 30
Not applicableUnknownNCT03673202
What this trial is testing

The Cxbladder Rule-out of Recurrent Urothelial Carcinoma

Who this might be right for
Bladder Cancer
London Health Sciences Centre 300
Testing effectiveness (Phase 2)Looking for participantsNCT06210490
What this trial is testing

A Clinical Study of the Efficacy and Safety of Disitamab Vedotin in Combination With Radiotherapy for the Adjuvant Treatment of HER2 Overexpressing UTUC Patients With High Risk Factors for Recurrence After Radical Surgery

Who this might be right for
Upper Urinary Tract Urothelial Carcinoma
Peking University First Hospital 60
Not applicableStudy completedNCT02700659
What this trial is testing

The Cxbladder Monitoring Study

Who this might be right for
Urothelial Carcinoma
Pacific Edge Limited 803
Testing effectiveness (Phase 2)UnknownNCT03544723
What this trial is testing

Safety and Efficacy of p53 Gene Therapy Combined With Immune Checkpoint Inhibitors in Solid Tumors.

Who this might be right for
Solid TumorLymphoma
MultiVir, Inc. 40
Testing effectiveness (Phase 2)Study completedNCT00003175
What this trial is testing

Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Medical Research Council 45
Testing effectiveness (Phase 2)Study completedNCT00310011
What this trial is testing

Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter
Wake Forest University Health Sciences 71
Testing effectiveness (Phase 2)Ended earlyNCT00363883
What this trial is testing

Vorinostat in Treating Patients With Locally Recurrent or Metastatic Cancer of the Urothelium

Who this might be right for
Localized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+2 more
National Cancer Institute (NCI) 14
Large-scale testing (Phase 3)Ended earlyNCT01200992
What this trial is testing

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Who this might be right for
Bladder NeoplasmNeoplasm Recurrence, LocalTransitional Cell, Carcinoma+2 more
Bioniche Life Sciences Inc. 84
Next Page